3 August 2009
Gene therapy - still a work in clinical and regulatory progress.
Hohmann EL. N Engl J Med. 2009 Jul 9;361(2):193-5.
Genomic copy number variation, human health, and disease.Wain LV, Armour JA, Tobin MD. Lancet. 2009 Jul 25;374(9686):340-50
Effect of genetic testing for risk of Alzheimer's disease.Kane RA, Kane RL. N Engl J Med. 2009 Jul 16;361(3):298-9.
Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing.Wright CF, Chitty LS. BMJ. 2009 Jul 6;339:b2451. doi: 10.1136/bmj.b2451.
No risk, no objections? Ethical pitfalls of cell-free fetal DNA and RNA testing.
Schmitz D, Henn W, Netzer C. BMJ. 2009 Jul 6;339:b2690. doi: 10.1136/bmj.b2690.
Protecting privacy and the public - limits on police use of bioidentifiers in Europe.Annas GJ. N Engl J Med. 2009 Jul 9;361(2):196-201.
The illusive gold standard in genetic ancestry testingSoo-Jin Lee S, Bolnick DA, Duster T, Ossorio P, Tallbear K. Science. 2009 Jul 3;325(5936):38-9.
Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications.Brown BD, Naldini L. Nat Rev Genet. 2009 Aug;10(8):578-85.
Gene defects and allergy.
Van Bever H, Lane B, Common J. BMJ. 2009 Jul 9;339:b1203. doi: 10.1136/bmj.b1203.
The changing moral focus of newborn screening.
Fleischman AR, Lin BK, Howse JL. Genet Med. 2009 Jul;11(7):507-9.
The HapMap and genome-wide association studies in diagnosis and therapy.Manolio TA, Collins FS. Annu Rev Med. 2009;60:443-56.
Molecular biology. Neutralizing toxic RNA.
Cooper TA. Science. 2009 Jul 17;325(5938):272-3.